+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Advanced Glycation End Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

  • ID: 5472655
  • Report
  • July 2021
  • Region: Global
  • 187 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • Beiersdorf AG
  • Cell Biolabs, Inc.
  • Estée Lauder Companies
  • L'Oréal S.A.
  • Merck KGaA
  • NuFACE

Advanced Glycation End Products Market - Scope of Report




This report on the global advanced glycation end products market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global advanced glycation end products market for the period from 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global advanced glycation end products market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the advanced glycation end products market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global advanced glycation end products market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global advanced glycation end products market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global advanced glycation end products market.

The report delves into the competitive landscape of the global advanced glycation end products market. Key players operating in the global advanced glycation end products market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global advanced glycation end products market profiled in this report.

Key Questions Answered in Advanced Glycation End Products Market Report

  • What is the sales/revenue generated by the advanced glycation end products market across all regions during the forecast period?
  • What are the opportunities in the global advanced glycation end products market?
  • What are the major drivers, restraints, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which type segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Advanced Glycation End Products Market - Research Objectives and Research Approach

The comprehensive report on the global advanced glycation end products market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global advanced glycation end products market in terms of type, application, end user, and region. Key segments under each criterion are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global advanced glycation end products market.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Beiersdorf AG
  • Cell Biolabs, Inc.
  • Estée Lauder Companies
  • L'Oréal S.A.
  • Merck KGaA
  • NuFACE
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Advanced Glycation End Products Market

4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Advanced Glycation End Products Market Analysis and Forecast, 2017-2031

5. Key Insights
5.1. Bioactivity of AGEs and RAGE: Flowchart
5.2. Key Trend Analysis
5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long Term Impact)

6. Global Advanced Glycation End Products Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Global Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
6.3.1. Non-fluorescent AGEs
6.3.1.1. Carboxymethyl-lysine (CML)
6.3.1.2. Carboxyethyl-lysine (CEL)
6.3.1.3. Pyrraline
6.3.2. Fluorescent AGEs
6.3.2.1. Pentosidine
6.3.2.2. Methylglyoxal-lysine dimer (MOLD)
6.4. Global Advanced Glycation End Products Market Attractiveness, by Type

7. Global Advanced Glycation End Products Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Global Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
7.3.1. Diabetic Complications
7.3.2. Cancer
7.3.3. Bone Diseases
7.3.4. Neurodegenerative Diseases
7.3.5. Others
7.4. Global Advanced Glycation End Products Market Attractiveness, by Application

8. Global Advanced Glycation End Products Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Global Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Others
8.4. Global Advanced Glycation End Products Market Attractiveness, by End-user

9. Global Advanced Glycation End Products Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Advanced Glycation End Products Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Advanced Glycation End Products Market Attractiveness, by Country/Region

10. North America Advanced Glycation End Products Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
10.2.1. Non-fluorescent AGEs
10.2.1.1. Carboxymethyl-lysine (CML)
10.2.1.2. Carboxyethyl-lysine (CEL)
10.2.1.3. Pyrraline
10.2.2. Fluorescent AGEs
10.2.2.1. Pentosidine
10.2.2.2. Methylglyoxal-lysine dimer (MOLD)
10.3. North America Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
10.3.1. Diabetic Complications
10.3.2. Cancer
10.3.3. Bone Diseases
10.3.4. Neurodegenerative Diseases
10.3.5. Others
10.4. North America Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
10.4.1. Hospitals
10.4.2. Specialty Clinics
10.4.3. Others
10.5. North America Advanced Glycation End Products Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. North America Advanced Glycation End Products Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country

11. Europe Advanced Glycation End Products Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
11.2.1. Non-fluorescent AGEs
11.2.1.1. Carboxymethyl-lysine (CML)
11.2.1.2. Carboxyethyl-lysine (CEL)
11.2.1.3. Pyrraline
11.2.2. Fluorescent AGEs
11.2.2.1. Pentosidine
11.2.2.2. Methylglyoxal-lysine dimer (MOLD)
11.3. Europe Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
11.3.1. Diabetic Complications
11.3.2. Cancer
11.3.3. Bone Diseases
11.3.4. Neurodegenerative Diseases
11.3.5. Others
11.4. Europe Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
11.4.1. Hospitals
11.4.2. Specialty Clinics
11.4.3. Others
11.5. Europe Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Advanced Glycation End Products Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region

12. Asia Pacific Advanced Glycation End Products Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
12.2.1. Non-fluorescent AGEs
12.2.1.1. Carboxymethyl-lysine (CML)
12.2.1.2. Carboxyethyl-lysine (CEL)
12.2.1.3. Pyrraline
12.2.2. Fluorescent AGEs
12.2.2.1. Pentosidine
12.2.2.2. Methylglyoxal-lysine dimer (MOLD)
12.3. Asia Pacific Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
12.3.1. Diabetic Complications
12.3.2. Cancer
12.3.3. Bone Diseases
12.3.4. Neurodegenerative Diseases
12.3.5. Others
12.4. Asia Pacific Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
12.4.1. Hospitals
12.4.2. Specialty Clinics
12.4.3. Others
12.5. Asia Pacific Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Advanced Glycation End Products Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region

13. Latin America Advanced Glycation End Products Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
13.2.1. Non-fluorescent AGEs
13.2.1.1. Carboxymethyl-lysine (CML)
13.2.1.2. Carboxyethyl-lysine (CEL)
13.2.1.3. Pyrraline
13.2.2. Fluorescent AGEs
13.2.2.1. Pentosidine
13.2.2.2. Methylglyoxal-lysine dimer (MOLD)
13.3. Latin America Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
13.3.1. Diabetic Complications
13.3.2. Cancer
13.3.3. Bone Diseases
13.3.4. Neurodegenerative Diseases
13.3.5. Others
13.4. Latin America Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
13.4.1. Hospitals
13.4.2. Specialty Clinics
13.4.3. Others
13.5. Latin America Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Advanced Glycation End Products Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region

14. Middle East & Africa Advanced Glycation End Products Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
14.2.1. Non-fluorescent AGEs
14.2.1.1. Carboxymethyl-lysine (CML)
14.2.1.2. Carboxyethyl-lysine (CEL)
14.2.1.3. Pyrraline
14.2.2. Fluorescent AGEs
14.2.2.1. Pentosidine
14.2.2.2. Methylglyoxal-lysine dimer (MOLD)
14.3. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
14.3.1. Diabetic Complications
14.3.2. Cancer
14.3.3. Bone Diseases
14.3.4. Neurodegenerative Diseases
14.3.5. Others
14.4. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
14.4.1. Hospitals
14.4.2. Specialty Clinics
14.4.3. Others
14.5. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Advanced Glycation End Products Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region

15. Competition Landscape
15.1. Market Share Analysis, by Company (2020)
15.2. Company Profiles
15.2.1. AbbVie, Inc. (Allergan Plc)
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Company Financials
15.2.1.3. Growth Strategies
15.2.1.4. SWOT Analysis
15.2.2. Merck KGaA
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Company Financials
15.2.2.3. Growth Strategies
15.2.2.4. SWOT Analysis
15.2.3. Takeda Pharmaceutical Company Limited
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Company Financials
15.2.3.3. Growth Strategies
15.2.3.4. SWOT Analysis
15.2.4. Estée Lauder Companies
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Company Financials
15.2.4.3. Growth Strategies
15.2.4.4. SWOT Analysis
15.2.5. Shiseido Company, Limited
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Company Financials
15.2.5.3. Growth Strategies
15.2.5.4. SWOT Analysis
15.2.6. Beiersdorf AG
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Company Financials
15.2.6.3. Growth Strategies
15.2.6.4. SWOT Analysis
15.2.7. L'Oréal S.A.
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Company Financials
15.2.7.3. Growth Strategies
15.2.7.4. SWOT Analysis
15.2.8. NuFACE
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Company Financials
15.2.8.3. Growth Strategies
15.2.8.4. SWOT Analysis
15.2.9. Rodan & Fields
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Company Financials
15.2.9.3. Growth Strategies
15.2.9.4. SWOT Analysis
15.2.10. PhotoMedex, Inc.
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Company Financials
15.2.10.3. Growth Strategies
15.2.10.4. SWOT Analysis
15.2.11. Ostium Cosmetics
15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.11.2. Company Financials
15.2.11.3. Growth Strategies
15.2.11.4. SWOT Analysis
15.2.12. Cell Biolabs, Inc.
15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.12.2. Company Financials
15.2.12.3. Growth Strategies
15.2.12.4. SWOT Analysis
15.2.13. Shanghai Korain Biotech Co., Ltd.
15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.13.2. Company Financials
15.2.13.3. Growth Strategies
15.2.13.4. SWOT Analysis

List of Tables
Table 01: Global Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 02: Global Advanced Glycation End Products Market Volume (Units) Forecast, by Non-fluorescent AGEs Type, 2017-2031
Table 03: Global Advanced Glycation End Products Market Volume (Units) Forecast, by Fluorescent AGEs Type, 2017-2031
Table 04: Global Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 05: Global Advanced Glycation End Products Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 06: Global Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 07: North America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 08: North America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 09: North America Advanced Glycation End Products Market Volume (Units) Forecast, by Non-fluorescent AGEs Type, 2017-2031
Table 10: North America Advanced Glycation End Products Market Volume (Units) Forecast, by Fluorescent AGEs Type, 2017-2031
Table 11: North America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 12: North America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 13: Europe Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Europe Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 15: Europe Advanced Glycation End Products Market Volume (Units) Forecast, by Non-fluorescent AGEs Type, 2017-2031
Table 16: Europe Advanced Glycation End Products Market Volume (Units) Forecast, by Fluorescent AGEs Type, 2017-2031
Table 17: Europe Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 18: Europe Advanced Glycation End Products Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 19: Asia Pacific Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 20: Asia Pacific Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 21: Asia Pacific Advanced Glycation End Products Market Volume (Units) Forecast, by Non-fluorescent AGEs Type, 2017-2031
Table 22: Asia Pacific Advanced Glycation End Products Market Volume (Units) Forecast, by Fluorescent AGEs Type, 2017-2031
Table 23: Asia Pacific Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 24: Asia Pacific Advanced Glycation End Products Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 25: Latin America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 26: Latin America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 27: Latin America Advanced Glycation End Products Market Volume (Units) Forecast, by Non-fluorescent AGEs Type, 2017-2031
Table 28: Latin America Advanced Glycation End Products Market Volume (Units) Forecast, by Fluorescent AGEs Type, 2017-2031
Table 29: Latin America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 30: Latin America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 31: Middle East & Africa Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 32: Middle East & Africa Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Type, 2017-2031
Table 33: Middle East & Africa Advanced Glycation End Products Market Volume (Units) Forecast, by Non-fluorescent AGEs Type, 2017-2031
Table 34: Middle East & Africa Advanced Glycation End Products Market Volume (Units) Forecast, by Fluorescent AGEs Type, 2017-2031
Table 35: Middle East & Africa Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 36: Middle East & Africa Advanced Glycation End Products Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures
Figure 01: Global Advanced Glycation End Products Market Value (US$ Mn) and Y-O-Y Growth (%) Forecast, 2017-2031
Figure 02: Global Advanced Glycation End Products Market Value Share, by Region, 2020
Figure 03: Global Advanced Glycation End Products Market Value Share Analysis, by Type, 2020 and 2031
Figure 04: Global Advanced Glycation End Products Market Value (US$ Mn), Non-fluorescent AGEs, 2017-2031
Figure 05: Global Advanced Glycation End Products Market Value (US$ Mn), Fluorescent AGEs, 2017-2031
Figure 06: Global Advanced Glycation End Products Market Attractiveness Analysis, by Type, 2021-2031
Figure 07: Global Advanced Glycation End Products Market Value Share Analysis, by Application, 2020 and 2031
Figure 08: Global Advanced Glycation End Products Market Value (US$ Mn), by Diabetic Complications, 2017-2031
Figure 09: Global Advanced Glycation End Products Market Value (US$ Mn), Cancer, 2017-2031
Figure 10: Global Advanced Glycation End Products Market Value (US$ Mn), by Bone Diseases, 2017-2031
Figure 11: Global Advanced Glycation End Products Market Value (US$ Mn), Neurodegenerative Diseases, 2017-2031
Figure 12: Global Advanced Glycation End Products Market Value (US$ Mn), by Others, 2017-2031
Figure 13: Global Advanced Glycation End Products Market Attractiveness Analysis, by Application, 2021-2031
Figure 14: Global Advanced Glycation End Products Market Value Share Analysis, by End-user, 2020 and 2031
Figure 15: Global Advanced Glycation End Products Market Value (US$ Mn), by Hospitals, 2017-2031
Figure 16: Global Advanced Glycation End Products Market Value (US$ Mn), Specialty Clinics , 2017-2031
Figure 17: Global Advanced Glycation End Products Market Value (US$ Mn), by Others, 2017-2031
Figure 18: Global Advanced Glycation End Products Market Attractiveness Analysis, by End-user, 2021-2031
Figure 19: Global Advanced Glycation End Products Market Value Share Analysis, by Region, 2020 and 2031
Figure 20: Global Advanced Glycation End Products Market Attractiveness Analysis, by Region
Figure 21: North America Advanced Glycation End Products Market Value (US$ Mn) Forecast Projection, 2017-2031
Figure 22: North America Advanced Glycation End Products Market Value Share (%), by Country, 2020 and 2031
Figure 23: North America Advanced Glycation End Products Market Attractiveness, by Country, 2021-2031
Figure 24: North America Advanced Glycation End Products Market Value Share Analysis, by Type, 2020 and 2031
Figure 25: North America Advanced Glycation End Products Market Attractiveness, by Type, 2021-2031
Figure 26: North America Advanced Glycation End Products Market Value Share Analysis, by Application, 2020 and 2031
Figure 27: North America Advanced Glycation End Products Market Attractiveness, by Application, 2021-2031
Figure 28: North America Advanced Glycation End Products Market Value Share Analysis, by End-user, 2020 and 2031
Figure 29: North America Advanced Glycation End Products Market Attractiveness, by End-user, 2021-2031
Figure 30: Europe Advanced Glycation End Products Market Value (US$ Mn) Forecast Projection, 2017-2031
Figure 31: Europe Advanced Glycation End Products Market Value Share (%), by Country/Sub-region, 2020 and 2031
Figure 32: Europe Advanced Glycation End Products Market Attractiveness, by Country/Sub-region, 2021-2031
Figure 33: Europe Advanced Glycation End Products Market Value Share Analysis, by Type, 2020 and 2031
Figure 34: Europe Advanced Glycation End Products Market Attractiveness, by Type, 2021-2031
Figure 35: Europe Advanced Glycation End Products Market Value Share Analysis, by Application, 2020 and 2031
Figure 36: Europe Advanced Glycation End Products Market Attractiveness, by Application, 2021-2031
Figure 37: Europe Advanced Glycation End Products Market Value Share Analysis, by End-user, 2020 and 2031
Figure 38: Europe Advanced Glycation End Products Market Attractiveness, by End-user, 2021-2031
Figure 39: Asia Pacific Advanced Glycation End Products Market Value (US$ Mn) Forecast Projection, 2017-2031
Figure 40: Asia Pacific Advanced Glycation End Products Market Value Share (%), by Country, 2020 and 2031
Figure 41: Asia Pacific Advanced Glycation End Products Market Attractiveness, by Country/Sub-region, 2021-2031
Figure 42: Asia Pacific Advanced Glycation End Products Market Value Share Analysis, by Type, 2020 and 2031
Figure 43: Asia Pacific Advanced Glycation End Products Market Attractiveness, by Type, 2021-2031
Figure 44: Asia Pacific Advanced Glycation End Products Market Value Share Analysis, by Application, 2020 and 2031
Figure 45: Asia Pacific Advanced Glycation End Products Market Attractiveness, by Application, 2021-2031
Figure 46: Asia Pacific Advanced Glycation End Products Market Value Share Analysis, by End-user, 2020 and 2031
Figure 47: Asia Pacific Advanced Glycation End Products Market Attractiveness, by End-user, 2021-2031
Figure 48: Latin America Advanced Glycation End Products Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 49: Latin America Advanced Glycation End Products Market Value Share (%), by Country/Sub-region, 2020 and 2031
Figure 50: Latin America Advanced Glycation End Products Market Attractiveness, by Country, 2021-2031
Figure 51: Latin America Advanced Glycation End Products Market Value Share Analysis, by Type, 2020 and 2031
Figure 52: Latin America Advanced Glycation End Products Market Attractiveness, by Type, 2021-2031
Figure 53: Latin America Advanced Glycation End Products Market Value Share Analysis, by Application, 2020 and 2031
Figure 54: Latin America Advanced Glycation End Products Market Attractiveness, by Application, 2021-2031
Figure 55: Latin America Advanced Glycation End Products Market Value Share Analysis, by End-user, 2020 and 2031
Figure 56: Latin America Advanced Glycation End Products Market Attractiveness, by End-user, 2021-2031
Figure 57: Middle East & Africa Advanced Glycation End Products Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 58: Middle East & Africa Advanced Glycation End Products Market Value Share, by Country/Sub-region, 2020-2031
Figure 59: Middle East & Africa Advanced Glycation End Products Market Attractiveness, by Country/Sub-region, 2021-2031
Figure 60: Middle East & Africa Advanced Glycation End Products Market Value Share Analysis, by Type, 2020 and 2031
Figure 61: Middle East & Africa Advanced Glycation End Products Market Attractiveness, by Type, 2021-2031
Figure 62: Middle East & Africa Advanced Glycation End Products Market Value Share Analysis, by Application, 2020 and 2031
Figure 63: Middle East & Africa Advanced Glycation End Products Market Attractiveness, by Application, 2021-2031
Figure 64: Middle East & Africa Advanced Glycation End Products Market Value Share Analysis, by End-user, 2020 and 2031
Figure 65: Middle East & Africa Advanced Glycation End Products Market Attractiveness, by End-user, 2021-2031
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • AbbVie, Inc. (Allergan Plc)
  • Merck KGaA
  • Takeda Pharmaceutical Company Limited
  • Estée Lauder Companies
  • Shiseido Company, Limited
  • Beiersdorf AG
  • L'Oréal S.A.
  • NuFACE
  • Rodan & Fields
  • PhotoMedex, Inc.
  • Ostium Cosmetics
  • Cell Biolabs, Inc.
  • Shanghai Korain Biotech Co., Ltd.
Note: Product cover images may vary from those shown